Nordson Q3 sales $742M (+12%), adjusted EPS $2.73 (+13%); board adds $500M buyback

NORDSON CORP

2025-Q3 EPS reported $5.83 revenue$2,039,867,000

Q3 sales $742M, up 12% YoY; organic sales up 2%; acquisition impact 8%.
Adjusted EPS $2.73, up 13% from $2.41; GAAP EPS $2.22.
Advanced Technology Solutions organic sales up 15%; Medical & Fluid up 32% (incl. Atrion).
Board authorized $500M share repurchase; total authorization ~$793M.
Full-year guidance confirmed: sales slightly below midpoint, adjusted EPS slightly above.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.